# AURA-2: Augmenting Urinary Reflex Activity

> **NCT05241379** · NA · COMPLETED · sponsor: **Amber Therapeutics Ltd** · enrollment: 13 (actual)

## Conditions studied

- Overactive Bladder
- Urge Incontinence

## Interventions

- **DEVICE:** Amber UI System

## Key facts

- **NCT ID:** NCT05241379
- **Lead sponsor:** Amber Therapeutics Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-11-30
- **Primary completion:** 2024-04-15
- **Final completion:** 2024-04-15
- **Target enrollment:** 13 (ACTUAL)
- **Last updated:** 2024-08-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05241379

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05241379, "AURA-2: Augmenting Urinary Reflex Activity". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05241379. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*